| 中文名 | CGP60474 |
| 英文名 | CGP60474 |
| 别名 | PKC抑制剂(CGP60474) 3-[[4-[2-[(3-氯苯基)氨基]-4-嘧啶基]-2-吡啶基]氨基]-1-丙醇 3-((4-(2-((3-氯苯基)氨基)嘧啶-4-基)吡啶-2-基)氨基)丙-1-醇 |
| 英文别名 | CS-506 CGP60474 CGP-60474 CGP 60474 3-[[4-[2-(3-chloroanilino)pyrimidin-4-yl]pyridin-2-yl]amino]propan-1-ol 3-[[4-[2-[(3-Chlorophenyl)amino]-4-pyrimidinyl]-2-pyridinyl]amino]-1-propanol 1-Propanol, 3-[[4-[2-[(3-chlorophenyl)amino]-4-pyrimidinyl]-2-pyridinyl]amino]- |
| CAS | 164658-13-3 |
| EINECS | 200-258-5 |
| 化学式 | C18H18ClN5O |
| 分子量 | 355.82 |
| 密度 | 1.356 |
| 熔点 | 144-147℃ |
| 沸点 | 630.6±65.0 °C(Predicted) |
| 酸度系数 | 14.93±0.10(Predicted) |
| 存储条件 | 2-8°C(protect from light) |
| 体外研究 | CGP60474 (Compound A) is a potent VEGFR-2 inhibitor, with an IC 50 of 84 nM. CGP60474 is also a PKC inhibitor, with competitive kinetics relative to ATP. |
| 体内研究 | CGP-60474 (10 mg/kg; i.p.) inhibits the IL-6 level and increases the survival rate in the LPS endotoxemia model. Animal Model: C57Bl/6 mice (LPS endotoxemia model) Dosage: 10 mg/kg Administration: I.p. Result: Had a higher survival rate. |
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 2.81 ml | 14.052 ml | 28.104 ml |
| 5 mM | 0.562 ml | 2.81 ml | 5.621 ml |
| 10 mM | 0.281 ml | 1.405 ml | 2.81 ml |
| 5 mM | 0.056 ml | 0.281 ml | 0.562 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!